The medical tech firm raised its full-year revenue guidance and set a new gross margin target of 58%-61% for 2026.
Senseonics increased its 2026 global net revenue guidance to a range of $62 million to $66 million, up from $60 million to $64 million. The adjustment reflects strong quarterly performance and confidence in continued growth, according to company leadership during its Q2 2026 earnings call.
The firm also raised its gross margin target to 58%-61%, signaling improved operational efficiency. Prior guidance had not specified a margin range for the year, but the update aligns with recent cost-management efforts.
No immediate market reaction was disclosed in the earnings call summary.